{"Topic" : "Hematologic Malignancies","subTopics" : [{ "subtopic" : "Updates in Multiple Myeloma","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "226967910"},{ "chapter" : "Newly Diagnosed Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "227075914"},{ "chapter" : "Relapsed and Relapsed/Refractory Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "223915712"},{ "chapter" : "Newer Agents and Updated Approvals for Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "223913757"},{ "chapter" : "Adjunctive and Supportive Care in Multiple Myeloma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-multiple-myeloma.aspx","VIMEOID" : "223916292"}]},{ "subtopic" : "Updates in Chronic Lymphocytic Leukemia","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "226953355"},{ "chapter" : "Newly Diagnosed CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223692963"},{ "chapter" : "Relapsed/Refractory CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223697922"},{ "chapter" : "Monoclonal Antibodies Used to Treat in CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223699563"},{ "chapter" : "Supportive Care in CLL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-chronic-lymphocytic-leukemia.aspx","VIMEOID" : "223700018"}]},{ "subtopic" : "Updates in Hodgkin Lymphoma","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "226965396"},{ "chapter" : "Newly Diagnosed and R/R Hodgkin Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "223904707"},{ "chapter" : "Novel Agents for the Treatment of cHL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "223908166"},{ "chapter" : "Survivorship in Hodgkin Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-hodgkin-lymphoma.aspx","VIMEOID" : "223911992"}]},{ "subtopic" : "Updates in Non-Hodgkin Lymphoma","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "226974296"},{ "chapter" : "Non-Hodgkin Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223918128"},{ "chapter" : "Diffuse Large B-Cell Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223919686"},{ "chapter" : "Follicular Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223920723"},{ "chapter" : "Mantle Cell Lymphoma", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223918156"},{ "chapter" : "Supportive Care for NHL", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma.aspx","VIMEOID" : "223919494"},{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "226970951"},{ "chapter" : "Strategies for Adherence to Oral Therapeutics", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223918178"},{ "chapter" : "Supporting Patients and Caregivers", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223921403"}]},{ "subtopic" : "Strategies for Adherence to Oral Therapeutics","chapters" : [{ "chapter" : "Full Session", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "226970951"},{ "chapter" : "Strategies for Adherence to Oral Therapeutics", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223918178"},{ "chapter" : "Supporting Patients and Caregivers", "Url" : "/apsho-rls/2017/hematologic-malignancies/updates-in-non-hodgkin-lymphoma/strategies-for-adherence-to-oral-therapeutics.aspx","VIMEOID" : "223921403"}]}]}ENDOFRESULT JADPRO 2017 Video List - JADPRO
 

JADPRO 2017 Video List

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here